top of page

VitriVax

More About the Company

Status:

Technology Type:

Active

Pharma

Fund:

Fund II

CU Anschutz Medical Campus Spinout:

Yes

Headquarters 
Location:

Boulder, CO, USA

Vaccine Adjuvants

Developer of thermostable vaccine platform technology known as ALTA (Atomic Layering Thermostable Antigen and Adjuvant). This technology alleviates the requirement for sustained vaccine refrigeration known as “cold chain”, which limits vaccine distribution to developing countries and vaccine stockpiling for future pandemics and bioterrorism threats.


The company is exploring multiple relationships with the CU immunology group and others on the CU Anschutz

campus.

bottom of page